Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP646220.RAXH3cMK-xgWk8MtsArFD5Y1uXnEdY8CKi2dSCrFv4X-w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP646220.RAXH3cMK-xgWk8MtsArFD5Y1uXnEdY8CKi2dSCrFv4X-w130_assertion type Assertion NP646220.RAXH3cMK-xgWk8MtsArFD5Y1uXnEdY8CKi2dSCrFv4X-w130_head.
- NP646220.RAXH3cMK-xgWk8MtsArFD5Y1uXnEdY8CKi2dSCrFv4X-w130_assertion description "[LOX-1 is increasingly viewed as a vascular disease biomarker and a potential therapeutic target in heart attack and stroke prevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646220.RAXH3cMK-xgWk8MtsArFD5Y1uXnEdY8CKi2dSCrFv4X-w130_provenance.
- NP646220.RAXH3cMK-xgWk8MtsArFD5Y1uXnEdY8CKi2dSCrFv4X-w130_assertion evidence source_evidence_literature NP646220.RAXH3cMK-xgWk8MtsArFD5Y1uXnEdY8CKi2dSCrFv4X-w130_provenance.
- NP646220.RAXH3cMK-xgWk8MtsArFD5Y1uXnEdY8CKi2dSCrFv4X-w130_assertion SIO_000772 18092947 NP646220.RAXH3cMK-xgWk8MtsArFD5Y1uXnEdY8CKi2dSCrFv4X-w130_provenance.
- NP646220.RAXH3cMK-xgWk8MtsArFD5Y1uXnEdY8CKi2dSCrFv4X-w130_assertion wasDerivedFrom befree-2016 NP646220.RAXH3cMK-xgWk8MtsArFD5Y1uXnEdY8CKi2dSCrFv4X-w130_provenance.
- NP646220.RAXH3cMK-xgWk8MtsArFD5Y1uXnEdY8CKi2dSCrFv4X-w130_assertion wasGeneratedBy ECO_0000203 NP646220.RAXH3cMK-xgWk8MtsArFD5Y1uXnEdY8CKi2dSCrFv4X-w130_provenance.